9

General Information


DRACP ID  DRACP00160

Peptide Name   9

Sequence  YX

Sequence Length  2

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HEp-2 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 6.2% inhibition at 10-6 M, 6.4% inhibition at 10-5 M, 8.2% inhibition at 10-4 M, 21.2% inhibition at 10-3 M MTT assay 72 h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 7.5% inhibition at 10-6 M, 6.1% inhibition at 10-5 M, 3.1% inhibition at 10-4 M, 14.8% inhibition at 10-3 M MTT assay 72 h 1
HBL Melanoma Carcinoma 3.9% inhibition at 10-5 M, 7.3% inhibition at 10-3 M MTT assay 72 h 1
HT-29 Colon adenocarcinoma Carcinoma 4.9% inhibition at 10-6 M, 8.9% inhibition at 10-5 M, 3.4% inhibition at 10-4 M, 20.8% inhibition at 10-3 M MTT assay 72 h 1
SW620 Colon adenocarcinoma Carcinoma 10.5% inhibition at 10-6 M, 21.9% inhibition at 10-5 M, 11.8% inhibition at 10-4 M, 17.9% inhibition at 10-3 M MTT assay 72 h 1
CaCo-2 Colon adenocarcinoma Carcinoma 3.7% inhibition at 10-6 M, 16.5% inhibition at 10-5 M, 8.4% inhibition at 10-4 M, 14.5% inhibition at 10-3 M MTT assay 72 h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma 1.1% inhibition at 10-5 M, 1.2% inhibition at 10-4 M, 17.8% inhibition at 10-3 M MTT assay 72 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  lead to apoptosis

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Cα -dialkylated glycine (Aaa2,S )

Chiral  L



Physicochemical Information


Formula  C9H9NO2

Absent amino acids  ACDEFGHIKLMNPQRSTVW

Common amino acids  YX

Mass  29119

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  -14

Hydrophobicity  -65

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  1490

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16722632

Title  Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity

Doi 10.1021/jm051026

Year  +2006

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.